```html

Lyophilized Serum Allergy (Anaphylactoid Reaction)

Overview

Lyophilized serum allergy—also referred to as an anaphylactoid reaction to lyophilized (freeze‑dried) blood‑derived products—occurs when the immune system reacts to proteins, stabilizers, or preservatives present in these preparations. Unlike classic IgE‑mediated anaphylaxis, anaphylactoid reactions can be triggered by direct mast‑cell activation without prior sensitization, but clinically they are indistinguishable from true anaphylaxis.

These reactions most often appear after the administration of lyophilized antisera, antivenoms, immunoglobulins, or serum‑derived vaccines. While the overall incidence of severe reactions is low (0.5‑2 % of administered doses according to the WHO’s Guidelines for the Production of Biologicals), the consequences can be life‑threatening, making prompt identification and management essential.

Who is affected? Anyone receiving a lyophilized serum product is at risk, but the following groups have higher reported rates:

• Patients with a history of allergic or atopic disorders (e.g., asthma, eczema, allergic rhinitis).
• Individuals who have previously received serum‑derived products and experienced mild reactions.
• Patients with underlying mast‑cell disorders such as systemic mastocytosis.
• Infants and elderly patients, whose immune regulation may differ.

Symptoms

Symptoms typically begin within minutes of exposure, but delayed presentations (up to 2 hours) are documented. The clinical picture mirrors anaphylaxis:

Cutaneous (skin)

• Urticaria (hives): Raised, itchy welts that may coalesce.
• Flushing or erythema: Warmth and redness, often on the face, neck, or torso.
• Angio‑edema: Swelling of lips, tongue, eyelids, or airway structures.
• Pruritus: Generalized itching.

Respiratory

• Wheezing, dyspnea, or a feeling of “tightness” in the chest.
• Stridor (high‑pitched sound) if upper airway edema occurs.
• Rapid breathing (tachypnea) and hypoxia.

Cardiovascular

• Hypotension (systolic <90 mm Hg) or a sudden drop in blood pressure.
• Palpitations, tachycardia, or bradycardia (in severe cases).
• Collapse, syncope, or altered mental status due to cerebral hypoperfusion.

Gastrointestinal

• Nausea, vomiting, abdominal cramping, or diarrhea.
• “Sense of doom” or generalized malaise.

Other

• Fever (rare, may indicate serum sickness rather than acute reaction).
• Headache or visual disturbances if cerebral hypoperfusion occurs.

Causes and Risk Factors

Primary Causes

• Protein antigens: Residual animal or human serum proteins can cross‑react with patient antibodies.
• Stabilizers and excipients: Compounds such as gelatin, bovine serum albumin, dextran, or polysorbate‑80 may be immunogenic.
• Direct mast‑cell activators: Certain peptides in antivenoms can trigger non‑IgE–mediated degranulation.
• Contaminants: Incomplete purification may leave trace endotoxins, leading to a cytokine surge.

Risk Factors

• Previous anaphylaxis or severe allergic reactions.
• Atopic background (asthma, eczema, allergic rhinitis).
• Concurrent use of β‑blockers or ACE inhibitors (may blunt epinephrine response).
• Pregnancy (immune modulation may increase susceptibility).
• High‑dose or rapid infusion of serum product.
• Genetic polymorphisms affecting FcεRI or mast‑cell receptors (still under investigation).

Diagnosis

Because the presentation mimics anaphylaxis, diagnosis is primarily clinical, supported by a focused history and targeted tests.

Clinical Assessment

1. Document timing of symptom onset relative to serum administration.
2. Identify skin, respiratory, cardiovascular, or gastrointestinal signs.
3. Apply the Anaphylaxis Clinical Criteria (e.g., involvement of ≥2 organ systems or hypotension after exposure).

Laboratory Tests (optional, not emergent)

• Serum tryptase: Peaks 1–2 hours after symptom onset; values >11.4 ng/mL suggest mast‑cell activation.
• Histamine levels: Rise within minutes but return to baseline quickly; often impractical.
• Specific IgE testing: May identify sensitization to animal proteins but is less useful for non‑IgE anaphylactoid reactions.
• Baseline CBC, electrolytes, and cardiac enzymes: Helpful if hypotension or cardiac involvement is suspected.

Skin Testing & Graded Challenge

For patients who require future serum therapy (e.g., antivenom for recurrent snake bites), allergy specialists may perform skin prick or intradermal testing with diluted product under controlled conditions. A graded (step‑wise) challenge can then be scheduled if testing is negative.

Treatment Options

Acute Management (Emergency)

1. Epinephrine: 0.3 mg IM into the anterolateral thigh (0.01 mg/kg for children, max 0.5 mg). Repeat every 5–15 minutes as needed.
2. Airway support: High‑flow oxygen, nebulized bronchodilators (albuterol), and, if needed, endotracheal intubation.
3. Intravenous fluids: Rapid bolus of isotonic crystalloids (20 mL/kg) to counteract hypotension.
4. Adjunct medications:
   • H1 antihistamines (diphenhydramine 25‑50 mg IV) – for cutaneous symptoms.
   • H2 blockers (cimetidine 300 mg IV) – may augment antihistamine effect.
   • Corticosteroids (methylprednisolone 1‑2 mg/kg IV) – to prevent biphasic reactions, though evidence is limited.
5. Monitoring: Continuous cardiac and pulse‑oximetry for at least 4–6 hours; observe for biphasic recurrence.

Long‑Term Management

• Prescribed epinephrine auto‑injector: Individuals with a documented reaction should carry a 0.3 mg (adult) or 0.15 mg (juvenile) device.
• Desensitization protocols: In specialized centers, a slow‑infusion desensitization can be performed for patients who must receive the serum repeatedly (e.g., antivenom for occupational risk).
• Medication review: Evaluate necessity of β‑blockers; consider switching to alternative antihypertensives if feasible.

Lifestyle & Supportive Measures

• Wear medical alert identification indicating “Lyophilized serum allergy – anaphylactoid reaction”.
• Educate family, coworkers, and school personnel on recognizing anaphylaxis and using epinephrine.
• Maintain a written emergency action plan (EPA) that outlines steps for the patient and caregivers.

Living with Lyophilized Serum Allergy (Anaphylactoid Reaction)

While the condition can be frightening, many patients lead normal lives with proper preparation.

Daily Management Tips

• Carry your auto‑injector: Keep it in a pocket, purse, or on a keychain; replace annually or after any activation.
• Medical ID: Use a bracelet or necklace that lists the allergy.
• Medication list: Keep an up‑to‑date list of all drugs, highlighting any that may potentiate reactions (e.g., β‑blockers).
• Vaccination & Travel: Before receiving any vaccine or biologic, inform healthcare providers of the allergy; they may choose a non‑serum‑based formulation.
• Psychological support: Anxiety about future reactions is common; counseling or support groups can improve quality of life.

Follow‑up Care

Schedule an appointment with an allergist‑immunologist within 1–2 weeks after any reaction to review the event, consider testing, and update the emergency plan.

Prevention

1. Detailed history: Prior to any serum product, clinicians should ask about previous reactions to animal‑derived proteins or serum products.
2. Pre‑medication: In high‑risk patients, a short course of antihistamines (e.g., cetirizine 10 mg PO 1 hour before infusion) and a corticosteroid (e.g., prednisone 50 mg PO the night before) may reduce mild cutaneous symptoms, though it does not replace epinephrine preparedness.
3. Slow infusion rates: Initiate at a low rate (e.g., 0.1 mL/min) and titrate up, monitoring vitals every 5 minutes for the first 30 minutes.
4. Use of recombinant or fully human alternatives: When available, these formulations have lower allergenicity.
5. Allergy testing before therapy: Particularly for patients with known serum allergies who need repeat dosing.

Complications

If not recognized and treated promptly, anaphylactoid reactions can lead to:

• Airway obstruction from angio‑edema or bronchospasm.
• Cardiogenic or distributive shock, potentially causing multi‑organ failure.
• Myocardial ischemia or arrhythmias secondary to severe hypotension.
• Renal injury due to prolonged hypoperfusion.
• Biphasic reaction occurring 4–12 hours after the initial event.
• Psychological sequelae (post‑traumatic stress, health‑related anxiety).

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. Anaphylaxis. https://www.mayoclinic.org. Accessed May 2026.
2. World Health Organization. Guidelines for the Production of Biologicals. 2022. Link.
3. Centers for Disease Control and Prevention. Anaphylaxis and Immunization. 2023. Link.
4. National Institute of Allergy and Infectious Diseases. Anaphylaxis Clinical Guidelines. 2021. Link.
5. Cleveland Clinic. Serum Allergy (Anaphylactoid Reaction). 2024. Link.
6. Simons FE, et al. “International Consensus on the Diagnosis and Management of Anaphylaxis.” World Allergy Organ J. 2020;13(6):100543.

```